default

Request a Quote

Christmas-Card-2024

Dear valued customer,

As the Holiday Season approaches, we want to keep you informed about our upcoming closures to ensure a seamless experience for you and your laboratory.

Please note that our office operations and order processing department will be closed during these times:

Christmas Day Closure:
Wednesday, December 25, 2024

 

New Year's Day Closure:
Wednesday, January 1, 2025


Half-Days:
Tuesday, December 24, 2024
Tuesday, December 31, 2024

We will be available to take your calls and orders until noon.

To facilitate a smooth transition during these closures, we kindly request that you plan your orders, requests, and inquiries accordingly. If you have any questions or require further information, please don't hesitate to contact our customer support team at custservice@hardydiagnostics.com or call us toll-free at 800-266-2222.

We appreciate your cooperation and understanding during this holiday period. Thank you for choosing Hardy Diagnostics as your trusted partner. All of us at Hardy Diagnostics would like to express our gratitude for your continued support and reliance on our services! From our lab to yours, Happy Holidays!

Monthly Archives: November 2023

  1. November 17, 2023

    Alarming increase in Cyclospora cases in the US

    A total of 1,957 laboratory-confirmed cases of cyclosporiasis have been reported in the United States so far this year.

    That is already surpassing the 1,129 cases reported in all of 2022. (1) The investigation of this outbreak is ongoing with no specific food item being identified as the source of most of these illnesses, although the outbreak count does include 20 patients in...

    Read More
  2. November 01, 2023

    New Antimicrobials for Difficult-to-Treat Pathogens: Sulbactam-Durlobactam and Rezafungin

    Healthcare professionals face a constant challenge with ever-evolving bacterial and fungal infections. Multidrug-resistant pathogens threaten the efficacy of existing treatments and highlight the need for new antimicrobial therapies. These microorganisms are typically resistant to the majority of antimicrobial agents, including carbapenems, making them difficult to treat. The Centers for Disease Control...

    Read More